Published August 22, 2013 | Version v1
Patent Open

C-CBL MUTATIONS AND USES THEREOF

Description

The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.

Files

US20130217012.pdf

Files (3.5 MB)

Name Size Download all
md5:4d70d32e2c29971c3ade407632c63e6e
3.5 MB Preview Download

Additional details

Identifiers

Patent number
US 201113701569 A
Patent application number
US 2013/0217012 A1
Other
oai:uchicago.tind.io:9498

Dates

Patent filed
2011-06-03

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine